Below is Validea's guru fundamental report for QUEST DIAGNOSTICS INC (DGX). Of the 22 guru strategies we follow, DGX rates highest using our Multi-Factor Investor model based on the published ...

Apple workers who are being tested at home will now have to do it twice a week, instead of once, a report says. Biocept rose Tuesday after it said it would provide laboratory-testing services to ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Fintel reports that on October 23, 2024, Baird upgraded their outlook for Quest Diagnostics (NYSE:DGX) from Neutral to Outperform. As of October 22, 2024, the average one-year price target for ...

As you’d expect, there’ll be various petrol and diesel options, with 220, 228 (yup, no more ‘i’ suffix for petrol BMWs), 218d, 220d and M235 xDrive (pictured here) among the known ones for ...

DGX benefits from secular tailwinds like aging populations and preventive medical testing, promising 10% annual returns and 6-8% annual dividend growth. DGX's financials have stabilized post-Covid ...

Mizuho Securities analyst Vijay Rakesh maintained his outperform (buy) rating on Broadcom stock while increasing his price target to $220. That would amount to a gain of 21% over the coming 12 to ...

After years of internet rumours, online teasers, and manufacturer hints, Yamaha have finally revealed a full production R9 supersport bike for 2025 featuring winglets, lean-sensitive electronics ...

Yamaha has finally updated the YZF-R3 for 2025 in the global markets. The latest update brings about new features and an updated design package. Let's take a closer look at the new Yamaha R3 via a ...

For a while now, all we've been able to do when it comes to the Yamaha R9 is speculate ... The R9's rear brakes match those of the R1 at 220 mm. When it hits dealership floors, the R9 will ...